Endoscopic Full-Thickness Resection for Extraluminal Gastric Submucosal Tumors - J of JGH - Jan,26

Based on the context provided, the study on "Endoscopic Full-Thickness Resection (EFTR) for Extraluminal Gastric Submucosal Tumors" likely highlights the feasibility, safety, and clinical outcomes of EFTR as a minimally invasive approach for managing gastric submucosal tumors with extraluminal growth. These tumors, which grow outward from the gastric wall, pose unique challenges compared to intraluminal lesions and have been inadequately studied in the past.

### Key Findings of the Study:

1. **Feasibility and Effectiveness:**

• EFTR was shown to be a feasible technique for removing gastric submucosal tumors with extraluminal growth, including those with completely extraluminal patterns.
• The procedure achieved a high rate of complete tumor removal with successful retrieval in most cases.

2. **Safety Profile:**

• Adverse events related to the procedure were infrequent and manageable, indicating an acceptable safety profile.
• The study supports the use of EFTR as a minimally invasive alternative to more invasive surgical techniques.

3. **Challenges and Complexity:**

• Tumor-related factors such as larger size and irregular morphology were associated with increased technical challenges, including difficulties in tumor extraction and longer operative times.
• These factors should be carefully considered during patient selection and pre-procedural planning.

4. **Oncologic Outcomes:**

• Long-term follow-up data revealed no evidence of local recurrence or distant metastasis, suggesting that EFTR provides oncologically adequate treatment for these tumors.

5. **Clinical Implications:**

• EFTR offers a promising treatment option for patients with gastric submucosal tumors that exhibit extraluminal growth, reducing the need for more invasive surgical procedures.
• Further studies, especially prospective trials, are needed to validate these findings and optimize patient selection criteria.

### Conclusion:

The study concludes that EFTR is a safe and effective minimally invasive method for treating gastric submucosal tumors with extraluminal growth. However, tumor characteristics such as size and morphology significantly influence procedural complexity. Prospective research is recommended to refine the technique and enhance outcomes.

If you are referring to a specific article in the Journal of Gastroenterology and Hepatology (JGH) published on January 26, this summary aligns with the general findings on the topic. However, for precise details, the original article should be consulted directly.